This inventor holds 1 USPTO granted patent. Top assignee: Centre for Cellular and Molecular Platforms. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022
Title: Shashank Rai: Innovator in Neuroinflammation Management
Introduction
Shashank Rai is a prominent inventor based in Mumbai, India. He has made significant contributions to the field of neurobiology, particularly in managing neuroinflammation and neurodegeneration. His innovative approach has the potential to impact the treatment of various neurodegenerative diseases.
Latest Patents
Shashank Rai holds 1 patent for his work titled "Methods and compositions for managing neuroinflammation and neurodegeneration." This patent describes a method of inhibiting neuroinflammation in neuron-surrounding cells. The method includes treating these cells with at least one tyrosine kinase inhibitor or sirtuin-2 inhibitor, or a combination thereof, to effectively inhibit neuroinflammation. Additionally, the patent outlines a method for managing neuroinflammation or neurodegeneration in subjects in need, which involves administering these inhibitors. The composition also includes at least one tyrosine kinase inhibitor or sirtuin-2 inhibitor, optionally along with a pharmaceutically acceptable excipient.
Career Highlights
Shashank Rai is currently associated with the Centre for Cellular and Molecular Platforms. His work at this institution has allowed him to collaborate with other experts in the field and contribute to groundbreaking research.
Collaborations
Some of his notable coworkers include Suresh Santhi Natesan and Ravi Manjithaya. Their collective efforts in research have further advanced the understanding of neuroinflammation and its implications.
Conclusion
Shashank Rai's innovative work in managing neuroinflammation and neurodegeneration showcases his dedication to advancing medical science. His contributions are paving the way for new treatment options in neurobiology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile